Vincenzo Barnaba (Vincenzo Barnaba) carried out his scientific research mainly at the Dipartimento of Internal Medicine of Roma "La Sapienza" – Medicine Faculty. Vincenzo Barnaba has been active as an immunologist for 25 years. The group lead by Vincenzo Barnaba has a long-standing interest in the pathogenesis of immune-mediated diseases, including autoimmune and viral (hepatitis viruses, HIV) diseases. In particular, the Vincenzo Barnaba group’s research aims at establishing the role of HBV and HCV in inducing chronic infection and the role of viruses in inducing autoimmunity, such as the ability of HIV to unveil cryptic self-epitopes.
Carlo Patrono, MD, is Professor and Chair of the Department of Pharmacology at the Catholic University School of Medicine in Rome, Italy.
Dr. Patrono trained as a postdoctoral fellow in New York with the late Solomon Berson and Nobel Laureate Rosalyn Yalow.
His main research interest is in the study of platelet activation and inhibition in atherothrombosis. His research has characterized the human pharmacology of aspirin as an inhibitor of platelet cyclooxygenase activity and provided the basis for the development of low-dose aspirin as an antithrombotic agent.
He is the Chairman of the Task Force on Antiplatelet Agents of the European Society of Cardiology and serves on the editorial board of Circulation and of Arteriosclerosis, Thrombosis, and Vascular Biology. He has been elected to membership in prestigious societies, including the Association of American Physicians, the Royal College of Physicians, the Academia Europaea and the Accademia dei Lincei.
Dr. Patrono has published over 180 original research articles and 100 book chapters. He has received the Alexander B. Gutman award from the Mount Sinai School of Medicine, the Distinguished Award in Neuroscience from the Louisiana State University, the 1998 International Aspirin® Award from Bayer AG and the 2007 John Vane Award from the William Harvey Research Institute of the University of London.
Antonio Musarò received his PhD in Biotechnology from Sapienza University of Rome. He was a Research fellow in Medicine at Harvard University (Boston, USA). He received an honorary position as Adjunct Associate Professor at the Edith Cowan University, Australia. He was Chief of the Interuniversity institute of myology. He currently holds a permanent position as full professor in Histology, Embryology and Biotechnology and he is the scientific coordinator of the PhD program in Morphogenesis and Tissue Engineering. The overall goal of his research program is to characterize the molecular aspects of muscle homeostasis, regeneration, and wasting. Antonio Musarò authored over 140 scientific publications. He is involved in various scientific dissemination activities; since 2010 he is scientific director of the "Science Festival" (Salento).
Andrea Bellelli, MD is full Professor of Biochemistry at Sapienza University of Rome and presently chairs the Department of Biochemical Sciences “Alessandro Rossi Fanelli” (2009-2015).
He was trained by Prof. Maurizio Brunori (Rome), and was visiting fellow at the Weizmann Institute of Science (Rehovot, Israel) and the Cornell University (Ithaca, New York, USA).
His main research interest is the study of structure-function relationships in oxygen carrying proteins and in oxido-reductases from mammals and, more recently from human parasites of the genera Schistosoma and Plasmodium. He studied and characterized several inhibitors of some these enzymes, notably of Thioredoxin Reductase and Thioredoxin Glutathione Reductase, some of which are used in therapy.
Andrea Bellelli is a member of the American Society of Biochemistry and Molecular Biology (ASBMB), and the Italian Society of Biochemistry and Molecular Biology (SIB), of which he also served as the General Secretary (2003-2006). Andrea Bellelli authored or co-authored over 100 scientific publications.
His main research interest has been the immunopathology of macrophages and the pathogenesis of lymphoproliferative diseases. He gave a major contribution in the understanding of the mechanisms of macrophage activation against tumors. He has investigated the role of soluble factors (cytokines) in the development of lymphoproliferative diseases with particular emphasis to Hodgkin's lymphoma.